Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $78.8B |
| FY2017, ended Dec 31, 2017 | $94.0B |
| FY2018, ended Dec 31, 2018 | $67.8B |
| FY2019, ended Dec 31, 2019 | $81.8B |
| FY2020, ended Dec 31, 2020 | $124B |
| FY2021, ended Dec 31, 2021 | $175B |
| FY2022, ended Dec 31, 2022 | $143B |
| FY2023, ended Dec 31, 2023 | $152B |
| FY2024, ended Dec 31, 2024 | $203B |
| FY2025, ended Dec 31, 2025 | $282B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $328B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $34.6B |
| FY2017, ended Dec 31, 2017 | $37.9B |
| FY2018, ended Dec 31, 2018 | $40.1B |
| FY2019, ended Dec 31, 2019 | $41.5B |
| FY2020, ended Dec 31, 2020 | $48.8B |
| FY2021, ended Dec 31, 2021 | $59.8B |
| FY2022, ended Dec 31, 2022 | $53.7B |
| FY2023, ended Dec 31, 2023 | $54.1B |
| FY2024, ended Dec 31, 2024 | $61.8B |
| FY2025, ended Dec 31, 2025 | $70.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $78.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.98B |
| FY2017, ended Dec 31, 2017 | $6.11B |
| FY2018, ended Dec 31, 2018 | $8.75B |
| FY2019, ended Dec 31, 2019 | $9.04B |
| FY2020, ended Dec 31, 2020 | $11.0B |
| FY2021, ended Dec 31, 2021 | $15.0B |
| FY2022, ended Dec 31, 2022 | $11.0B |
| FY2023, ended Dec 31, 2023 | $9.09B |
| FY2024, ended Dec 31, 2024 | $13.4B |
| FY2025, ended Dec 31, 2025 | $16.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $20.2B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $77.4B |
| FY2017, ended Dec 31, 2017 | $80.4B |
| FY2018, ended Dec 31, 2018 | $87.2B |
| FY2019, ended Dec 31, 2019 | $82.2B |
| FY2020, ended Dec 31, 2020 | $106B |
| FY2021, ended Dec 31, 2021 | $128B |
| FY2022, ended Dec 31, 2022 | $128B |
| FY2023, ended Dec 31, 2023 | $89.2B |
| FY2024, ended Dec 31, 2024 | $105B |
| FY2025, ended Dec 31, 2025 | $112B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $160B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $166B |
| FY2017, ended Dec 31, 2017 | $193B |
| FY2018, ended Dec 31, 2018 | $188B |
| FY2019, ended Dec 31, 2019 | $190B |
| FY2020, ended Dec 31, 2020 | $213B |
| FY2021, ended Dec 31, 2021 | $227B |
| FY2022, ended Dec 31, 2022 | $234B |
| FY2023, ended Dec 31, 2023 | $261B |
| FY2024, ended Dec 31, 2024 | $284B |
| FY2025, ended Dec 31, 2025 | $342B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $383B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 15.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.87B |
| FY2017, ended Dec 31, 2017 | 1.79B |
| FY2018, ended Dec 31, 2018 | 1.71B |
| FY2019, ended Dec 31, 2019 | 1.60B |
| FY2020, ended Dec 31, 2020 | 1.81B |
| FY2021, ended Dec 31, 2021 | 1.78B |
| FY2022, ended Dec 31, 2022 | 1.68B |
| FY2023, ended Dec 31, 2023 | 1.64B |
| FY2024, ended Dec 31, 2024 | 1.61B |
| FY2025, ended Dec 31, 2025 | 1.59B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.57B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.14B |
| FY2017, ended Dec 31, 2017 | $1.03B |
| FY2018, ended Dec 31, 2018 | $920M |
| FY2019, ended Dec 31, 2019 | $1.15B |
| FY2020, ended Dec 31, 2020 | $1.31B |
| FY2021, ended Dec 31, 2021 | $2.08B |
| FY2022, ended Dec 31, 2022 | $1.88B |
| FY2023, ended Dec 31, 2023 | $1.71B |
| FY2024, ended Dec 31, 2024 | $1.62B |
| FY2025, ended Dec 31, 2025 | $1.93B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.05B |
Valuation
At current price- Market Cap
- $294B
- P/E
- 14.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.8×
- Price / Book
- 2.5×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $78.0B
- Revenue Growth YoY
- 18.0%
- Revenue CAGR 3Y
- 9.6%
- Revenue CAGR 5Y
- 7.7%
- EPS Growth YoY
- 40.2%
- Net Income Growth YoY
- 36.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 25.8%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 18.0%
Earnings
Trailing 12 months- Net Income
- $20.2B
- EPS (diluted)
- $12.38
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $160B
- Total Debt
- $383B
- Net Debt
- $223B
- Total Assets
- $1.68T
- Total Liabilities
- $1.56T
- Shareholders' Equity
- $116B
Cash Flow
Trailing 12 months- Operating Cash Flow
- −$15.6B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 2.2%
- Dividend / Share
- $4.15
- Beta (5Y)
- 1.22
Every ratio is calculated from the company’s reported figures.